We are live on
!
Find out more
Mariner Portfolio holdings
AUM
$85.7B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
-0.96%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$85.7B
AUM Growth
+$1.66B
(+2%)
Cap. Flow
+$4.07B
Cap. Flow
% of AUM
4.75%
Top 10 Holdings %
Top 10 Hldgs %
27.24%
Holding
3,909
New
385
Increased
1,802
Reduced
1,276
Closed
364
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$274M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$184M |
| 3 |
Microsoft
MSFT
|
+$172M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$170M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$179M |
| 2 |
T-Mobile US
TMUS
|
+$162M |
| 3 |
ProShares Ultra Semiconductors
USD
|
+$135M |
| 4 |
ServiceNow
NOW
|
+$128M |
| 5 |
Abbott
ABT
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 7.66% |
| 3 | Healthcare | 5.22% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Industrials | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Lucid Diagnostics
LUCD
$180M
| $24.3K | ﹤0.01% |
21,153
+7,293
| +53% | +$9.28K |
|
3477
Cardiff Oncology
CRDF
$66.9M
| $23.4K | ﹤0.01% |
+14,451
| New | +$29.7K |
|
|
NVX
3478
NOVONIX
NVX
$106M
| $22.7K | ﹤0.01% |
32,908
+15,384
| +88% | +$14.9K |
|
3479
Veritone
VERI
$105M
| $22.5K | ﹤0.01% |
+11,419
| New | +$38.6K |
|
3480
Kaltura
KLTR
$220M
| $22.4K | ﹤0.01% |
+18,333
| New | +$26.1K |
|
3481
Douglas Elliman
DOUG
$160M
| $21.6K | ﹤0.01% |
+13,194
| New | +$30.6K |
|
3482
INmune Bio
INMB
$48.9M
| $21.5K | ﹤0.01% |
19,043
+8,793
| +86% | +$12.5K |
|
|
NFGC
3483
New Found Gold
NFGC
$565M
| $20.8K | ﹤0.01% |
+10,745
| New | +$28.8K |
|
3484
PSQ Holdings
PSQH
$11.6M
| $20.4K | ﹤0.01% |
2,566
-5
| -0.2% | -$59 |
|
3485
Lineage Cell Therapeutics
LCTX
$277M
| $19.8K | ﹤0.01% |
12,514
-584
| -4% | -$985 |
|
3486
Accuray
ARAY
$28.7M
| $19.1K | ﹤0.01% |
49,226
+21,624
| +78% | +$13.4K |
|
3487
Nerdy
NRDY
$105M
| $19.1K | ﹤0.01% |
+23,380
| New | +$22.4K |
|
3488
Definitive Healthcare
DH
$74M
| $18.7K | ﹤0.01% |
+15,241
| New | +$26.5K |
|
|
NUAIW
3489
New Era Energy & Digital Inc Warrants
NUAIW
$15.6M
| $18.2K | ﹤0.01% |
10,000
| – | – |
|
3490
DocGo
DCGO
$66.6M
| $17.7K | ﹤0.01% |
+28,073
| New | +$21.1K |
|
3491
MIRA Pharmaceuticals
MIRA
$39M
| $17.7K | ﹤0.01% |
16,500
| – | – |
|
3492
Lexicon Pharmaceuticals
LXRX
$999M
| $17.3K | ﹤0.01% |
+11,072
| New | +$16.1K |
|
|
NAKA
3493
Nakamoto Inc
NAKA
$84.7M
| $16.9K | ﹤0.01% |
+1,917
| New | +$24.3K |
|
3494
Paramount Gold Nevada
PZG
$96.9M
| $16.6K | ﹤0.01% |
+10,011
| New | +$18.9K |
|
3495
Nauticus Robotics
KITT
$5.58M
| $15.5K | ﹤0.01% |
+3,889
| New | +$26.4K |
|
3496
Tenaya Therapeutics
TNYA
$171M
| $15.2K | ﹤0.01% |
22,000
-71
| -0.3% | -$52 |
|
3497
BARK
BARK
$78.3M
| $14.7K | ﹤0.01% |
1,451
+864
| +147% | +$13.3K |
|
3498
Arbe Robotics
ARBE
$90.9M
| $14.4K | ﹤0.01% |
23,627
-2,800
| -11% | -$2.91K |
|
|
FFAI
3499
Faraday Future Intelligent Electric
FFAI
$28.9M
| $14.4K | ﹤0.01% |
+52,280
| New | +$36K |
|
3500
Pulmonx
LUNG
$51.1M
| $14.3K | ﹤0.01% |
+11,067
| New | +$18.3K |
|
Similar funds
Mariner's Q1 2026 Portfolio in Review
As of Q1 2026, Mariner held 3,909 positions worth $85.7B, up 2% from $84B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mariner deployed $4.07B of net new capital in Q1 2026, opening 385 new positions and adding to 1,802 existing holdings. Its largest new stake was BNY Mellon Dynamic Value ETF: 960,263 shares worth $28.5M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $179M trimmed.
- Mariner's largest Q1 2026 buy was BNY Mellon Dynamic Value ETF: 960,263 shares worth $28.5M.
- Mariner added most to Apollo Global Management in Q1 2026, an estimated $274M increase.
- Mariner's biggest Q1 2026 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $179M.
- Mariner fully exited Exact Sciences in Q1 2026, selling an estimated $11.1M.
- Mariner's ten largest holdings make up 27% of its $85.7B portfolio in Q1 2026.
- Mariner opened 385 new positions and closed 364 in Q1 2026.
- Mariner's portfolio value rose 2% quarter-over-quarter to $85.7B.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.